繁 简 About Us Company Profile Corporate Structure Milestones Core Business R&D and Production Base Zhuhai R&D and Production Base Kunming R&D and Production Base Global Sales Network Chinese Medicine Development Chinese Medicine R&D Chinese Medicinal Materials Decoction Slices Biomedical Technology and Products Tianda Products Pipeline Quality Healthcare Services Investor Relations Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications Sustainability Our Sustainable Development ESG Report Careers Wort At Tianda Recruitment Vacancies Internship Programmes Trainee Programmes Media Centre Press Releases Media Coverage Contact Us 2012 Select Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 28.11.2012 【匯港通訊】天大藥業(00455)中期純利2455.84萬元增長3% 不派息 (Chinese version only) 28.11.2012 【新報】天大重組 聚焦製藥發展 (Chinese version only) 28.11.2012 【Oriental Daily】天大藥業擬上游購併 (Chinese version only) 28.11.2012 【Apple Daily】天大擴雲南珠海生產線 (Chinese version only) 27.11.2012 【ETNet】《神州民企》天大藥業：主打產品利潤上升，未有計劃增持盟生 (Chinese version only) 19.11.2012 【Oriental Daily】天大主打醫藥業務 (Chinese version only) 19.11.2012 【ETNet】《神州民企》天大控股（00455）將改名為天大藥業 (Chinese version only) 18.09.2012 【輝立證券】輝立證券研究報告 – 天大控股（455.HK） (Chinese version only) 29.06.2012 【Wen Wei Po】天大控股改名天大藥業 (Chinese version only) 27.06.2012 【ETNet】天大控股：計劃拓展醫療設備業務及俄羅斯市場，或收購藥廠 (Chinese version only) 27.06.2012 【Tencent】天大控股：計畫拓展醫療設備業務及俄羅斯市場 (Chinese version only)
